Clinical trials recruiting in Morrow, Georgia

Phase breakdown

Conditions recruiting in Morrow, Georgia

Recruiting trials in Morrow, Georgia

• A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
  NCT07661329 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
  NCT06267274 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
  NCT05401357 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Morrow, Georgia?

4 recruiting trials have at least one study site in Morrow, Georgia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.